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The accumulation of mitochondrial DNA mutations has been proposed as a potential mechanism in the physiological processes of ageing and
age-related disease. Although mitochondria have long been anticipated as a perpetrator of ageing, there was little experimental evidence to link
these changes directly with the cellular pathology of ageing. Recently, considerable progress in understanding basic mitochondrial genetics and in
identifying acquired mtDNA mutations in ageing has been made. Furthermore, the creation of mtDNA-mutator mice has provided the first direct
evidence that accelerating the mtDNA mutation rate can result in premature ageing, consistent with the view that loss of mitochondrial function is
a major causal factor in ageing. This review will, therefore, focus on recent developments in ageing research related to the role played by mtDNA.
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Over three decades ago, Harman was one of the first to
propose that mitochondria play a central role in ageing [1]. The
initial free radical theory suggested that reactive oxygen species
(ROS), which are constantly generated through normal meta-
bolism, are causing ageing, as well as associated degenerative
diseases, by introducing irreversible damage to membranes,
proteins and DNA [2]. Early studies on isolated mitochondria,
where many of the redox elements were held at artificial state,
have suggested that 1–4% of the total oxygen consumed was
used to generate ROS [3]. However, subsequent studies, under
more physiological conditions, have estimated this basal value
to ∼0.2% [4]. Even with this lower estimated value of ROS
generation, the mitochondrial electron transport chain (ETC)
still remains the major site (∼90%) of ROS production in a cell.
This fact has lead to the suggestion that mitochondria are also
prime targets for oxidative damage and that accumulation of
defective mitochondria is a major contributor to ageing [1].
Indeed, an increased number of dysfunctional mitochondria are
found in a number of animal models and human tissues with
increasing age (for review, see [5]). Besides, mitochondria are⁎ Tel.: +46 8 5858 3677; fax: +46 8 779 5383.
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DNA, mtDNA, with the limited arsenal of DNA repair
processes, further supporting the idea that mitochondria might
be particularly sensitive to accumulation of damage. The
mitochondrial theory of ageing, a correlate of the free radical
theory, is also based around the idea of a vicious cycle (Fig. 1a),
in which somatic mutations of mitochondrial DNA (mtDNA)
provoke respiratory chain dysfunction leading to enhanced ROS
production and in turn to the accumulation of further mtDNA
mutations [1].
2. Basics of mtDNA genetics
Mammalian mtDNA is a circular double-stranded molecule
of ∼16.5 kb and encodes 13 proteins, all of which are respira-
tory chain subunits, and 24 RNA components (22 tRNAs and
2 rRNAs) necessary for mitochondrial protein synthesis [6]. It
has been estimated that mammalian mitochondria contain
∼1500 different proteins and it is thus evident that the majority
of the mitochondrial proteins are encoded by nuclear DNA
(nDNA), translated in the cytoplasm and transported into
mitochondria [6]. The biogenesis of the respiratory chain is
therefore dependent on an intricate and poorly understood
interaction between mtDNA and nDNA. Importantly, mtDNA
is completely dependent on nuclear-encoded proteins for its
Fig. 1. (a) MtDNA mutations accumulate progressively during life and are
directly responsible for a measurable deficiency in cellular oxidative
phosphorylation activity, leading to an enhanced ROS production. In turn,
increased ROS production results in an increased rate of mtDNA damage and
mutagenesis, thus causing a ‘vicious cycle’ of exponentially increasing
oxidative damage and dysfunction, which ultimately culminates in ageing and
death. (b) A three–five times increase in somatic mtDNA mutations in mtDNA
mutator mice has been shown to result in defective respiration and therefore
energy deficiency in individual cells. This is associated with increased
apoptosis, about three times reduction in lifespan and development of
premature onset of ageing-related phenotypes such as weight loss, reduced
subcutaneous fat, alopecia, kyphosis, osteoporosis, anemia, reduced fertility and
cardiomyopathy.
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dimeric polymerase gamma (Polg) throughout the lifespan, in
both proliferating and post-mitotic cells [7]. We have recently
demonstrated that Polg is the only DNA polymerase capable of
maintaining mtDNA in mammalian mitochondria and that its
presence is absolutely essential for the organogenesis during
mammalian embryonic development [8].
Inheritance of mtDNA is almost exclusively maternal,
although some exceptions have been reported [9,10]. As each
mammalian somatic cell contains ∼1000–10,000 copies of
mtDNA, a pathogenic mutation could be presented in all
(homoplasmy) or just a few copies (heteroplasmy) of the mole-
cule [6]. Heteroplasmic mtDNAmutations segregate during cell
division because there is no mechanism to ensure that every
mtDNA molecule is replicated once during each cell cycle [7].A minimal threshold level of a pathogenic mtDNA mutation
must be present in a cell to cause respiratory chain deficiency. It
has been shown that different types of heteroplasmic mtDNA
mutations have different thresholds for induction of respiratory
chain dysfunction, ranging from 90% for some tRNA mutations
to 60% for mtDNA deletions [6]. Random distribution of
mtDNA molecules during cell division can lead to increased
amounts of mutant mtDNA molecules in one of the daughter
cells. Thus, a cell carrying low levels of mutated molecules
could give rise to one of relatively high levels, which in turn will
affect oxidative phosphorylation in that cell.
Patients carrying heteroplasmic mtDNA mutations often
have widely varying levels of mutated mtDNA in different
organs and even in different cells of a single organ [6]. Besides,
the intracellular distribution of mtDNA molecules plays a cru-
cial role in the manifestation of the effects of mtDNAmutations.
MtDNA molecules have a dynamic compartmentalization
within the mitochondria, which controls the capacity of the
mtDNA molecules and/or their products to interact with each
other. This further increases the possible functional differences
between mitochondria located in different intracellular sites and
could be illustrated by functional differences between the
synaptic and the cell body mitochondria in neurons [11].
Furthermore, recent evidence suggests that there is an age-
dependent, selective decrease in the rate of oxidative phos-
phorylation in the intermyofibrillar (located between cardio-
myocytes) cardiac mitochondria, but not in the subsarcolemmal
mitochondria (located below the plasma membrane) [12].
2.1. mtDNA mutations associated with ageing
Although mtDNA only comprise around 1% of the total
DNA present in the cell a large amount of evidence suggests
that its contribution in cellular physiology may well be far
greater than suggested by its amount or size. This has been be
illustrated by the importance of mitochondria and mtDNA in the
ageing process.
2.2. mtDNA deletions
One of the first pieces of evidence of mitochondrial defects
in post-mitotic tissues was the detection of large deletions in
mtDNA in cells from ageing human tissues [13]. The highest
levels of ageing-associated multiple mtDNA deletions are
observed in post-mitotic tissues with high-energy demands such
as heart [13,14], skeletal muscle [14] and brain [5,14,15].
Among them, the most frequently reported mtDNA deletion
associated with ageing is a 4977-bp deletion (mtDNA-4977,
also known as the “common” deletion) that specifically disrupts
mitochondrial complexes I, IV and V of the electron transport
chain (ETC) [13]. Interestingly, the amount of the 4977-bp
deletion varies more than 1000-fold between different regions
of the brain, with the highest levels accumulating in aged
substantia nigra, caudate, and putamen [15] while there was no
age-related increase in cerebellum [15,16]. Besides, multiple
large-scale deletions of mtDNA can be easily detected, but at
different levels in a number of tissues of elderly subjects [16].
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ageing individuals are 3715 and 6278-bp deletions, whose
frequencies approached that of the 4977-bp deletion [17].
Similarly, an increase with age in the incidence of 5 and 6 kb
deletions has been detected in human liver mtDNA [18].
Ageing-associated mtDNA deletions are also found to accu-
mulate in other species, including monkeys [19], rats [20], mice
[21] and nematodes [22].
Although mtDNA mutations have been detected in a variety
of ageing human tissues, it is still poorly understood as to how
they occur. Sequence analysis of the reported deletions of human
mtDNA revealed that they occurredmore frequently between the
two origins of replication. The breakpoints of many of these
mtDNA deletions are flanked by direct repeat sequences.
Slipped mispairing during DNA replication between these direct
repeat sequences, homologous replication, and topoisomerase II
cleavage have been suggested to be the possible mechanisms for
mtDNA deletions. A recent detailed study of 263 different
human mtDNA deletions has shown that direct repeats are
uniformly distributed throughout the mitochondrial genome and
their distribution was different from the distribution of deletion
breakpoints. It has been proposed that two 13-pair direct repeats
beginning at nucleotides 8470 and 13,447 could be linked to the
formation of most deleted mtDNA molecules, suggesting a
common mechanism related to mtDNA replication [23].
MtDNA deletions occurring in man are always present in a
heteroplasmic form and biochemical defects and clinical
symptoms are not evident until the proportion of the genomes
having the deletion reaches a certain critical value [24]. Thus, it
was considered unlikely that ageing-related deletions played a
significant role in the loss of mitochondrial function that occurs in
cells from old individuals, because of the much lower levels of
deletions associated with ageing. However, the level of a parti-
cular mtDNA deletion, reported in most of the quantitative
analyses, was examined in the total tissue or total cell population.
Some more recent studies have taken into account a possible
intercellular or intracellular mosaicism in the distribution of the
deletion, and performed analysis on single cells rather than total
tissue extracts. Sequencing of full-length mtDNA from single
human cardiomyocytes of four centenarians showed that levels of
a single large mtDNA deletion could accumulate to between 11%
and 64% [25]. Each of these cells carried only one type of deleted
mtDNA, while different cells carried different types, strongly
suggesting a clonal expansion of a single initial mutational event
[25]. In contrast to cardiomyocytes, individual skeletal muscle
fibers from old human subjects, contained high amounts of
multiple mtDNA deletions and, in some of them, no intact wild-
type mtDNAwas detected [26]. However, in some other studies
performed on individual myofibrils, no such extensive accumu-
lation of ageing-dependent largemtDNAdeletions were observed
[27]. Therefore, due to the intercellular or intracellular mosaicism
in the distribution of the deletions, it is clear that a tissue dys-
function may arise even when the overall level of the deletions is
relatively low.
Additional support for the role of ageing-associated mtDNA
deletions comes from experiments linking them to mitochon-
drial dysfunction. It has been proposed that mtDNA deletionslead to ageing-associated myofibril atrophy and loss that cause
sarcopenia [28]. The impairment of ATP production caused by
ageing-associated accumulation of mtDNA deletions may
eventually result in cell death. A correlation between the rate
of an ageing-related COX deficiency of the muscle fibers and
mtDNA depletion or incidence of the 5 kb common deletion,
was clearly established in the extraocular muscle fibers from
70 year old subjects [29]. Furthermore, the segmental colo-
calization of skeletal muscle mtDNA deletions with oxidative
mtDNA damage, and a COX deficiency was also observed.
Similarly, a focal accumulation of large deletions in isolated
COX-deficient muscle fibers has been reported [30].
3. Point mutations
In contrast to a widely recognized ageing-associated accu-
mulation of mtDNA deletions in different tissues, until re-
cently, an age-dependent accumulation of mtDNA point
mutations was not that apparent. This is in contrast with
more than 100 different mtDNA mutations that have been
associated with both mitochondrial diseases and common
disorders like diabetes or Parkinson's disease [31]. One possi-
ble explanation for this phenomenon could be a lack of relia-
ble methods for detecting heteroplasmic point mutations in
ageing tissues.
In fact, the first screenings for ageing-related mtDNA point
mutations were focused on pathogenic mutations commonly
found in mitochondrial diseases, as the assays were already
developed and available. Thus, a tRNALys A8344G mutation
that is associated with Myoclonic Epilepsy with Ragged-Red
Fibers (MERRF) was found to accumulate up to 2% in extra-
ocular muscles of older subjects, while tRNALeu(UUR)
A3243G transition that is found in Mitochondrial Encephalo-
myopathy with Lactic Acidosis and Stroke-like episodes
(MELAS) accumulates up to 1% of the total mtDNA in the
same muscle [32]. The low frequency reported for the mutations
mentioned above raised questions about their possible relevance
for the ageing processes. More recently, a detailed study on
isolated cytochrome c oxidase (COX) deficient muscle fibers
from old individuals was performed in search for point
mutations in five different tRNA genes. High levels of clonally
expanded point mutations were identified in eight COX
deficient fibers but in none of the normal ones. They included
the previously described pathogenic tRNALeu (UUR) A3243G
and tRNALys A8344G mutations and two original mutations in
tRNAMet T4460C and G4421A [30]. These data show that
mitochondrial DNA point mutations are associated with COX
deficient muscle fiber segments in ageing. Furthermore, focal
accumulation of these mutations causes significant impairment
of mitochondrial function in individual cells in spite of low
overall levels of mitochondrial DNA mutations in muscle [30].
However, others have failed to detect clonal expansion of
specific point mutations in isolated muscle fibers. This
discrepancy could be partly due to different regions used in a
search for mtDNA point mutations, as the later group was using
two small mtDNA regions that did not include tRNA genes
[33]. Indeed, it seems that the mitochondrial tRNA genes could
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their stem–loop structures [31].
Some parts of the central nervous system (CNS) have also
been shown to accumulate COX deficient cell, in age dependent
manner. Hippocampal pyramidal neurons and choroidal epithe-
lial cells accumulate COX deficient cells in larger quantities
with increasing age. It has been proposed that hippocampal
pyramidal neurons may have a lower threshold for degeneration
with COX deficiency contributing to the higher neuronal loss in
these regions [34]. Loss of COX activity (complex IV), but
preservation of succinate dehydrogenase (SDH) (complex II)
activity strongly suggests the involvement of mtDNA in the
pathogenesis of the enzyme effect. This is supported by another
study were two different regions of brain cortex were analyzed
for the decreased COX activity and that is associated to the level
of point mutations in mtDNA encoded cytochrome oxidase 1
(CO1) gene [35]. This study has shown that there is 2–3 times
increase in the level of random point mutations in elderly
subjects over 65 years of age than in young controls. Inte-
restingly, although the collective mutational load was high, the
majority of mutations found in brain were individually rare.
Thus, individual mutations are generally present at burdens
much less than the minimum 50% threshold generally required
before mitochondrial dysfunction is observed [35]. Neverthe-
less, the aggregate burden of somatic point mutations correlates
negatively with COX activity.
Another region that has been shown to be important in
human ageing is the mtDNA main control region (D-loop
region) that contains the initiation sites for transcription and
replication of mtDNA. In the mitochondrial genome, this region
is the most variable segment of mammalian mtDNA and thus
has a higher possibility of harboring mutations during ageing
[36]. The first report of the occurrence of an ageing-dependent
large accumulation of point mutations in the D-loop region of
mtDNA comes from senescent human fibroblasts [37]. Sys-
tematic analysis of the D-loop region on human skin fibroblasts
from a large number of unrelated normal individuals 20-week
faetal to 101 years, revealed a number of different mtDNA
mutations [37]. The most interesting class of mutations was
represented by specific point mutations, like a T414G trans-
version that occurred only in a large proportion of individuals
older than 65 years (57%), and was very abundant, present in up
to 50% of mtDNA molecules [37]. Besides, in longitudinal
studies, in which two fibroblast skin samples were taken from
the same individuals, within an interval of 15–19 years, specific
mutations appeared only with advancing age [37]. Ageing-
dependent accumulation of specific mutations, in the D-loop
region of human mtDNA, was further observed in skeletal
muscle. However, most of the 26 individuals between 53 and
92 years of age accumulated two new point mutations (A189G
and T408A), while a fibroblast specific mutation T414G was
not found [38]. These two new mutations were not found in
fibroblasts or in leucocytes from older individuals, pointing to
their tissue specificity. Recently, single cell analysis of the main
mtDNA control region from cardiomyocytes of 51–109 year
old individuals revealed accumulation of a single specific point
mutation up to 100% of the total mtDNA in an individual cell[39]. Striking tissue specificity of ageing-associated mtDNA
point mutations in the main control region of human mtDNA
suggests involvement of specific mutagenic machinery and to
the functional relevance of these mutations.
However, when the whole control region of murine mtDNA
was analyzed in the search for ageing-associated point
mutations, different results were obtained [40]. In order to
increase the chance to detect potential mtDNA mutations, tis-
sues with high-energy demand were analyzed, including brain,
skeletal muscle, heart, and eye. Unlike what has been reported
for human mtDNA, no evidence for an accumulation of specific
mouse mtDNA mutations in mtDNA control region at an
abundance above 3%, was found [40].
One explanation for the lack of mtDNA mutation accumu-
lation in mouse is that mouse has a shorter life span, so there is
insufficient time to accumulate a significant amount of mtDNA
mutations. However, it has been suggested that the rate of
mitochondrial mutagenesis is faster in mouse than human,
which should fully compensate for the difference in life spans
[41] and multiple mtDNA deletions have been reported to
accumulate in the brain and muscle in ageing mice [21]. These
results indicate that further experiments are needed to under-
stand more clearly the distribution and accumulation of mtDNA
mutations in different species and different regions of mtDNA.
3.1. Lessons from the mtDNA mutator mice
Until recently, most of the above data were seen more as a
consequence than a driving force of ageing as it showed only a
correlative connection to ageing. However, we have recently
provided evidence in direct support for the involvement of
mitochondria in the process of ageing. We created homozygous
knock-in mice (mtDNA mutator mice) expressing a proofread-
ing deficient form of the nuclear-encoded mitochondrial DNA
polymerase (Polg) [42].
Recombinant mtDNA polymerase holoenzyme, containing a
PolgA subunit, bearing the Asp→Ala exonuclease domain
mutation, had a profound reduction of exonuclease activity with
no decrease in DNA polymerase activity. The mtDNA-mutator
mice are born in normal Mendelian proportion and have a
normal appearance until the age of ∼25 weeks at which a slight
kyphosis (curvation of the spine, morphological sign of osteo-
porosis in mice) and hair loss could be noticed. As the animals
got older they developed a wide range of premature ageing
phenotypes such as weight loss, reduced subcutaneous fat,
alopecia, kyphosis, osteoporosis, anaemia with progressive
decrease in circulating red blood cells, reduced fertility, heart
enlargement and sarcopenia [42]. The median life span of the
mtDNA-mutator mice was approximately 46 weeks and all of
them died before the age of 61 weeks [42].
MtDNA mutator mice have a widespread tissue distribution
of a linear, deleted mtDNA molecule up to ∼12 kb in length.
Commonly deleted region localized to the small arc between the
two origins of mtDNA replication. The amount of deleted
mtDNA did not change over time and the levels of the deleted
mtDNAwere comparable in all investigated tissues. The deleted
molecules in mtDNA mutator mice are not replicated indicating
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deficient exonuclease activity [42].
Furthermore, mtDNA mutator mice displayed a progressive
and random accumulation of mtDNA point mutations that was
rather uniform between tissues, suggesting that much of the
mutation accumulation may occur during embryonic and/or
faetal development [42]. Indeed, the mutation load was already
substantial in mtDNA mutator at embryonic day 13.5
(7.8±0.4 mut/10 kb compared to 1.5±0.9 mut/10 kb in wild-
type embryos) [43]. The mitochondrial theory of ageing
predicts that levels of mtDNA mutations should increase expo-
nentially as a consequence of a vicious cycle by accelerating
oxidative stress. On the other hand, point mutations in mtDNA
mutator accumulate in approximately linear fashion, from
midgestation to late adult life, implying that there is no vicious
cycle (Fig. 1a and b) [43]. Furthermore, there were no obvious
mutational hot spots in mtDNA-mutator mice, although
mutation load in the non-coding control region was lower
than in the cytochrome b gene. Still, it is possible that mutation
load might be an underestimate because cells with the highest
levels of deleterious mutations may be lost due to cell death and/
or replicative disadvantage. However, the spectrum of mtDNA
mutations in protein coding genes in mtDNA mutator mice is
apparently random, even though a large amount of cell death
would lead to preferential loss of cells with mutations at codon
positions 1 and 2 [42,43].
Loss of vital cells in which mtDNA mutations have
accumulated beyond a critical threshold, via apoptosis or repli-
cative senescence, may be the critical process that manifests as
premature ageing and reduced lifespan. Additional support for
this comes from a series of tissue-specific Tfam knockout mouse
strains, with reduced mtDNA expression and severe respiratory
chain deficiency in different organs [44–48]. Loss of Tfam leads
to considerable cell death by apoptotic or and/or necrotic path-
ways in embryos [44,48] and differentiated tissues such as heart
[44,45], neurons [46] and insulin-secretingβ-cells [47]. However,
only minor induction of defense mechanisms against reactive
oxygen species (ROS) in these knockouts has been found. Unlike
tissue-specific Tfam knockouts, where the effects on respiration
and oxidative phosphorylation are essentially quantitative, the
mtDNA-mutator creates an apparently random set of point muta-
tions in genes for respiratory chain subunits. Surprisingly, in-
creased levels of mtDNA mutations were not associated with
increased ROS production or increased oxidative stress in
mtDNA mutator mice (Fig. 1b) [43]. In agreement with this, we
observed normal sensitivity to oxidative stress-induced cell death
in mouse embryonic fibroblasts from mtDNA mutator mice,
despite the presence of a severe respiratory-chain dysfunction
[43].
Others have independently developed a very similar mtDNA
mutator mouse model [49]. They have also proposed that tissue
dysfunction was likely to arise from increased apoptosis, as mi-
totic tissues of this second mtDNA mutator mice (thymus,
intestine, testis) had increased levels of activated caspase-3 as
early as 3 months of age [49]. Postmitotic tissues, like skeletal
muscle, also displayed increased activated caspase-3 but at a later
stage, coinciding with tissue degeneration [49].The premature ageing phenotypes in mtDNA mutator mice
are thus not generated by a vicious cycle of massively increased
oxidative stress accompanied by exponential accumulation of
mtDNA mutations. We propose instead that respiratory-chain
dysfunction is the primary inducer of premature ageing in the
mtDNA mutator mice. Furthermore, results from mtDNA
mutator mice indicate that clonal expansion of specific mtDNA
mutations in aged individual cells will lead to their loss but how
will this affect organismal survival is still unclear.
4. Conclusions
There is a growing body of evidence that mitochondria play
a central role in the ageing process. Mitochondrial dysfunction
and mtDNA mutations have been shown to amplify during the
course of ageing. Results obtained from mtDNA mutator mice
have further strengthened the role of mitochondria in organis-
mal ageing. However, lack of increased oxidative stress in the
mtDNA mutator mice has raised reasonable doubts in the direct
connection of mtDNA mutations with increased ROS produc-
tion. However, this does not imply that there is no age depen-
dent accumulation of oxidative stress and increased ROS
production, neither it is a final proof that oxidative stress does
not play an important role in the generation of mtDNA muta-
tions. Indeed, there is extensive literature demonstrating ampli-
fied oxidative damage to the different cell compartments with
increasing age, not least in mitochondria and mtDNA. However,
reviewing this literature is beyond the scope of this article
that was intended to focus primarily on the role of mtDNA
mutations in ageing.
The role of mitochondrial dysfunction in human ageing must
now be revisited and additional studies of respiratory chain
capacity and mtDNA mutation load in different organs from
humans of different ages must be performed to further validate
this hypothesis. It may also be possible to perform additional
genetic experiments in the mouse to test this hypothesis, for
example creating mice with enhanced mtDNA polymerase
proofreading capacity or enhanced mtDNA repair capacity.
Such mouse mutants should have a longer than normal life span
if somatic mtDNA mutations have a causative role in ageing.
Mitochondria are now at the center stage in human disease and
ageing and we should look forward to exciting developments in
this field during the coming years.
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